Drugs / PTH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00473265 | May 2004 → Jan 2011 | hypoparathyroidism | John P. Bilezikian | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00473265 ↗ |
| Action | Restore | “administration of PTH restores skeletal dynamics and structure” NCT00473265 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant human parathyroid hormone (1-84)” PMID 29972871 ↗ Aug 2018 |